ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,110Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 315

$731K Total Retail Price of All Prescriptions

Rank: 30 out of 315

485 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 569 470 1 3
HYDROCHLOROTHIAZIDE 563 522 2 16
SIMVASTATIN 450 399 3 1
LOSARTAN POTASSIUM 395 379 4 4
LOVASTATIN 384 344 5 8
AMLODIPINE BESYLATE 345 306 6 2
FUROSEMIDE 299 245 7 15
METOPROLOL TARTRATE 248 208 8 18
PRAVASTATIN SODIUM 221 167 9 10
LEVOTHYROXINE SODIUM 217 193 10 6
CARVEDILOL 211 187 11 22
METFORMIN HCL 187 158 12 7
HYDROCODONE-ACETAMINOPHEN 181 134 S3 13 19
ALLOPURINOL 179 158 14 14
OMEPRAZOLE 166 112 15 9
ATORVASTATIN CALCIUM 148 110 16 5
TAMSULOSIN HCL 138 122 17 21
GLIPIZIDE 131 104 18 30
ZOLPIDEM TARTRATE 128 103 19 29
LANTUS SOLOSTAR 118 110 20 69
POTASSIUM CHLORIDE 106 91 21 36
METOPROLOL SUCCINATE 104 62 22 13
ADVAIR DISKUS 94 92 23 46
ATENOLOL 93 92 24 11
PANTOPRAZOLE SODIUM 93 71 24 35
NAMENDA 91 91 26 38
DONEPEZIL HCL 89 89 27 28
PROAIR HFA 86 67 28 52
ESCITALOPRAM OXALATE 84 70 29 108
PREDNISONE 82 75 30 41
RANITIDINE HCL 82 51 30 42
NAPROXEN 81 68 32 88
FENTANYL 80 77 S2 33 160
CLOPIDOGREL 78 65 34 25
WARFARIN SODIUM 77 69 35 20
ALENDRONATE SODIUM 75 68 36 12
LEVEMIR FLEXPEN 73 57 37 158
FINASTERIDE 73 68 37 60
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 61 39 149
JANUVIA 71 53 40 31
CELEBREX 68 68 41 34
SPIRIVA 63 56 42 74
HYDRALAZINE HCL 62 60 43 98
ABILIFY 62 43 43 303
AMOXICILLIN 61 50 45 65
DIGOXIN 60 46 46 45
CARBIDOPA-LEVODOPA 60 60 46 136
TRAMADOL HCL 58 28 48 59
AVODART 57 57 49 113
GABAPENTIN 56 34 50 37
PLAVIX 56 49 50 40
SYMBICORT 55 45 52 135
MIRTAZAPINE 55 50 52 68
PHENYTOIN SODIUM EXTENDED 53 32 54 321
ISOSORBIDE MONONITRATE ER 53 49 54 92
AZITHROMYCIN 53 47 54 39
POLYETHYLENE GLYCOL 3350 52 46 57 106
NITROSTAT 51 30 58 259
OXYCODONE HCL 50 15 S2 59 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.